carmen marino
University of Salerno department of Pharmacy · Anna Maria D'Ursi
Research Interests
Carmen has focused her studies on biology field, in particular in omics techniques. Since her thesis period she has focused on the characterization of metabolomic profiles obtained through the analysis of biofluids and tissues with NMR spectroscopy.
Biography
Carmen Marino is a Ph.D student at the University of Salerno. She gratuated in Science Biologists at the University of Sannio and specialized with honors in Biology at University of Salerno. From January to October 2020 carried out research, at the laboratory of Pharmaceutical Chemistry of Professor Anna Maria D'Ursi, within the project called "Fighting cancer resistance: integrated multidisciplinary platform for a project innovative technology to oncotherapies". Currently enrolled in the third year of PhD in Pharmaceutical Sciences, she dedicates herself to Research "Metabolomics approach in the study of molecular mechanisms of pathologies and in identification of new pharmacological targets".
Education
She graduated in Science Biologists at the University of Sannio and specialized with honors in Biology at University of Salerno. From January to October 2020 carried out research, at the laboratory of Pharmaceutical Chemistry of Professor Anna Maria D'Ursi, within the project called "Fighting cancer resistance: integrated multidisciplinary platform for a project innovative technology to oncotherapies". She holds a PhD in pharmaceutical sciences and is currently a research fellow at UNISA
Recent Scopus Publications
- Untargeted 1H NMR-based metabolomics unveils distinct circulating biochemical signatures between treatment-resistant and non-treatment-resistant schizophrenia patients: a pilot study
- Epigenetic alterations of AKT1 orchestrate a metabolic reprogramming in advanced lipedema: translational insights from an integrated multi-omics study
- Analyzing Nicotine Action Against Amyloid Toxicity by NMR-Pharmacometabolomics: An Exploratory Study
- Cell Surface Markers of Mesenchymal Stem Cells: Current Knowledge and Advances in Characterization Technologies
- 1H-NMR-based metabolomics identifies disrupted betaine metabolism as distinct serum signature of pre-frailty
Links
- ORCID https://orcid.org/0000-0003-2587-505X
- Scopus https://www.scopus.com/authid/detail.uri?authorId=57216432818